Doctor profile · Federal record
Dr. Daniel Michalik, MD
Dermatology Physician (CMS: Dermatology) · Elmhurst, IL
- NPI 1639674575
- Accepts Medicare
- MIPS 91.4 / 100 · 2023
- 8 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
172 E Schiller St
Elmhurst, IL 601262816
(331) 221-9005 - Mailing address
-
4201 Winfield RD Fl 3
Warrenville, IL 605554025
Credentials & registration
- NPI registered
- March 2018 — 8 yrs on file
- Profile last updated
- July 27, 2022
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Illinois #036159088
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639674575. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,360
Distinct HCPCS
10
Medicare allowed
$95,928
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 437 | 96 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 161 | 123 | $57 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 149 | 118 | $93 | |
11102 |
Biopsy of related skin growth, first growth | 125 | 108 | $103 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 122 | 122 | $117 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 92 | 92 | $171 | |
11103 |
Biopsy of related skin growth, each additional growth | 65 | 35 | $53 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 62 | 45 | $131 | |
17110 |
Destruction of skin growth, 1-14 growths | 46 | 38 | $118 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 35 | 35 | $76 |
In context: peer comparison
Among 4 peers in Elmhurst Dermatology Physician, average services per provider: 314. This provider delivers 4.3× the peer median.Open Payments
Industry payments received
All-time total
$2,166
Transactions
94
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 17 | $1,068.11 | |
| Dermavant Sciences, INC. | 37 | $330.69 | |
| Ucb, INC. | 16 | $149.06 | |
| Leo Pharma INC. | 5 | $102.82 | |
| Regeneron Healthcare Solutions, INC. | 4 | $102.43 | |
| Janssen Biotech, INC. | 1 | $79.99 | |
| Pfizer INC. | 3 | $48.69 | |
| Genzyme Corporation | 1 | $43.02 | |
| Novartis Pharmaceuticals Corporation | 2 | $42.99 | |
| Verrica Pharmaceuticals INC. | 1 | $35.75 | |
| Almirall LLC | 1 | $29.13 | |
| Sandoz INC. | 2 | $27.24 | |
| Lilly USA, LLC | 2 | $26.90 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $26.19 | |
| Arcutis Biotherapeutics, INC. | 1 | $22.83 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
368
Patients
238
Total drug cost
$11,654
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 94 | 76 | $1,200 |
| Clobetasol Propionate | Generic | 67 | 44 | $4,263 |
| Ketoconazole | Generic | 48 | 28 | $1,205 |
| Hydrocortisone | Generic | 36 | 30 | $214 |
| Fluocinonide | Generic | 31 | 23 | $1,612 |
| Doxycycline Hyclate | Generic | 22 | 12 | $456 |
| Mupirocin | Generic | 22 | 13 | $261 |
| Minoxidil | Generic | 14 | 0 | $103 |
| Gentamicin Sulfate | Generic | 12 | 12 | $516 |
| Metronidazole | Generic | 11 | 0 | $1,359 |
Frequently asked questions
What is Dr. Daniel Michalik's medical specialty?
Dr. Daniel Michalik practices Dermatology Physician in Elmhurst, IL.
Where does Dr. Daniel Michalik practice?
Dr. Daniel Michalik practices at 172 E Schiller St, Elmhurst, IL 601262816. Office phone: 3312219005.
What is Dr. Daniel Michalik's NPI?
Dr. Daniel Michalik's National Provider Identifier (NPI) is 1639674575, issued by NPPES.
Does Dr. Daniel Michalik accept Medicare assignment?
Yes. Dr. Daniel Michalik accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daniel Michalik commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.